A manuka honey company says new technology that increases the bio-activity properties of the honey has the potential to increase its earnings tenfold.
Manuka Health has unveiled the patented technology, called CycloPower, at the annual NZBio technology showcase in Auckland this week.
The company says the new technology will see manuka honey products more akin to pharmaceutical products than jars of honey.
Chief executive Kerry Paul says it can be produced in the form of a powder which can then be made into a tablet or lozenge, ointment or cream.
A wide range of applications could be developed, such as eye drops, nasal sprays, topical creams and oral capsules.
This has the potential to lift the value earned from 1kg of manuka honey by 10 times.
Mr Paul says Manuka Health is releasing the first two products using CycloPower this week, a throat lozenge and a propolis powder.